164 related articles for article (PubMed ID: 30284996)
1. Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats.
Chekhun VF; Storchai DM; Todor IN; Borikun TV; Lukianova NY
Exp Oncol; 2018 Oct; 40(3):200-204. PubMed ID: 30284996
[TBL] [Abstract][Full Text] [Related]
2. The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma.
Lozovska YV; Andrusishina IM; Lukianova NY; Burlaka AP; Naleskina LA; Todor IN; Chekhun VF
Exp Oncol; 2019 Mar; 41(1):20-25. PubMed ID: 30932415
[TBL] [Abstract][Full Text] [Related]
3. Sesquiterpene lactones of Moquiniastrum polymorphum subsp. floccosum have antineoplastic effects in Walker-256 tumor-bearing rats.
Martins GG; Lívero FA; Stolf AM; Kopruszinski CM; Cardoso CC; Beltrame OC; Queiroz-Telles JE; Strapasson RL; Stefanello MÉ; Oude-Elferink R; Acco A
Chem Biol Interact; 2015 Feb; 228():46-56. PubMed ID: 25616030
[TBL] [Abstract][Full Text] [Related]
4. Ruthenium complex exerts antineoplastic effects that are mediated by oxidative stress without inducing toxicity in Walker-256 tumor-bearing rats.
Alves de Souza CE; Alves de Souza HM; Stipp MC; Corso CR; Galindo CM; Cardoso CR; Dittrich RL; de Souza Ramos EA; Klassen G; Carlos RM; Correia Cadena SMS; Acco A
Free Radic Biol Med; 2017 Sep; 110():228-239. PubMed ID: 28629835
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of biochemical and morphological parameters in rats with Walker 256 and Walker 256/DOX carcinosarcoma.
Yushko LA; Sarnatskaya VV; Sakhno LA; Hudenko NV; Paziuk LM; Maslenny VN; Melnyk VO; Nikolaev VG
Exp Oncol; 2021 Mar; 43(1):21-25. PubMed ID: 33785723
[TBL] [Abstract][Full Text] [Related]
6. Regression of Walker 256 carcinosarcoma in vasopressin-deficient Brattleboro rats is accompanied by a changed laminin pattern.
Khegay II; Ivanova LN
Biochem Genet; 2015 Apr; 53(1-3):1-7. PubMed ID: 25854851
[TBL] [Abstract][Full Text] [Related]
7. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
[TBL] [Abstract][Full Text] [Related]
8. Reduced Walker 256 carcinosarcoma growth in vasopressin-deficient Brattleboro rats.
Khegay II; Popova NA; Ivanova LN
Tumour Biol; 2010 Dec; 31(6):569-73. PubMed ID: 20559788
[TBL] [Abstract][Full Text] [Related]
9. Energy controllable steep pulse (ECSP) treatment suppresses tumor growth in rats implanted with Walker 256 carcinosarcoma cells through apoptosis and an antitumor immune response.
Luo XD; Sun JC; Liu F; Hu LN; Dong XJ; Sun DN; Xiao J
Oncol Res; 2012; 20(1):31-7. PubMed ID: 23035363
[TBL] [Abstract][Full Text] [Related]
10. Walker 256/S carcinosarcoma causes osteoporosis-like changes through ectopical secretion of luteinizing hormone-releasing hormone.
Waki Y; Nomura M; Kasugai S; Ohya K; Miyamoto K
Cancer Res; 1999 Mar; 59(6):1219-24. PubMed ID: 10096551
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of a prophylactic treatment with the bisphosphonate 3-amino-1-hydroxypropane-1,1-bisphosphonic acid on the development of tumor osteopathies in the rat: experimental studies with the Walker carcinosarcoma 256.
Krempien B; Wingen F; Eichmann T; Müller M; Schmähl D
Oncology; 1988; 45(1):41-6. PubMed ID: 3340393
[TBL] [Abstract][Full Text] [Related]
12. Structural changes of serum albumin in response to oxidative stress caused by Walker-256 carcinosarcoma growth.
Sarnatskaya VV; Yushko LA; Prokopenko IV; Hudenko NV; Maslenny VN; Paziuk LM; Bubnovskaya LN; Nikolaev VG
Exp Oncol; 2020 Mar; 42(1):40-45. PubMed ID: 32231185
[TBL] [Abstract][Full Text] [Related]
13. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
14. Toxicity of intrathecally administered cytotoxic drugs and their antitumor activity against an intrathecal Walker 256 carcinosarcoma model for meningeal carcinomatosis in the rat.
Kooistra KL; Rodriguez M; Powis G
Cancer Res; 1989 Feb; 49(4):977-82. PubMed ID: 2912564
[TBL] [Abstract][Full Text] [Related]
15. Radiographic and histological evaluation of bisphosphonate alendronate and metotrexate effects on rat mandibles inoculated with Walker 256 carcinosarcoma.
Alves AP; Pessoa Cdo O; Costa-Lotufo L; Moraes Filho MO
Acta Cir Bras; 2007; 22(6):457-64. PubMed ID: 18235934
[TBL] [Abstract][Full Text] [Related]
16. Osseous and intestinal compartments in the humoral hypercalcemia of malignancy associated to Walker 256 tumor in rats.
Torres R; de la Piedra C; Rapado A
Oncology; 1993; 50(2):148-52. PubMed ID: 8451038
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic experiments with spores of strain Clostridium butyricum and Cyclophosphamide in Jensen sarcoma, Walker carcinoma, and DS carcinosarcoma of the rat (author's transl)].
Kretschmer H; Ludewig R; Hambsch K
Arch Geschwulstforsch; 1974; 44(1):65-9. PubMed ID: 4447441
[No Abstract] [Full Text] [Related]
18. [Effect of plant biocomposites based on Georgian tea "per se" and in combination with cisplatin on Walker carcinosarcoma W-256 and Guerin's carcinoma growth rate in rats].
Zalietok SP; Orlovs'kyĭ OA; Hohol' SV; Samoĭlenko OA; Hulua L; Kvesitadze HI
Lik Sprava; 2006 Dec; (8):89-93. PubMed ID: 17427433
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study for the expression of Bcl-2 family proteins in Walker 256 carcinosarcoma cells under the influence of cytostatic drugs.
Ovsjanko EV; Lushnikova EL; Larionov PM; Arkhipov SA; Nepomnyashchikh LM; Efremov AV; Ovsjanko YU
Bull Exp Biol Med; 2009 Oct; 148(4):650-5. PubMed ID: 20396763
[TBL] [Abstract][Full Text] [Related]
20. Aprotinin and growth of Walker 256 carcinosarcoma in the rat.
Thomson AW; Pugh-Humphreys RG; Horne CH; Tweedle DJ
Br J Cancer; 1977 Apr; 35(4):454-60. PubMed ID: 300627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
